Asthma treatment study for people using high-dose inhalers
Part of Lungs & breathing clinical trials.
This study tests if a treatment plan called GDMT can help people whose asthma is not well controlled even with high-dose inhaled steroids and long-acting bronchodilators. It is for adults who have had at least one asthma flare-up in the past year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had asthma for more than 6 months and have proof that your airways are reversible (like a breathing test shows improvement after medicine).
- You currently use a high or medium dose of inhaled steroids combined with a long-acting bronchodilator.
- You have had one or more asthma attacks in the past year that required steroids, an ER visit, or a hospital stay.
- You have never been diagnosed with 'severe asthma' or used asthma biologic medicines.
- You have no recent lung infections or other major health conditions that would make the study unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
This study tests whether switching to a higher-dose or extrafine triple inhaler helps people whose asthma is still uncontrolled on their current medium-dose combination inhaler. It focuses on improving small-airway function, which may lead to better symptom control.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This trial tests a new drug called MG-K10 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if the drug can reduce asthma attacks and improve breathing. You may be able to join if you have had asthma for at least a year, use high-dose inhalers plus another controller medicine, and have had a recent flare-up.
This study tests a new medicine called GB-0895 for people with severe asthma that is not well controlled by current treatments. The medicine is added to your usual asthma medications to see if it can reduce asthma attacks and improve breathing.
This study tests a new add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this medicine can reduce asthma attacks and improve breathing.
Hear when a new Uncontrolled Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.